Evidence map›Paper›PMID 36619349›Full record

ArticleAdvanced genetics (Hoboken, N.J.)2022

In Vitro and In Vivo Analysis of Extracellular Vesicle-Mediated Metastasis Using a Bright, Red-Shifted Bioluminescent Reporter Protein.

Gloria I Perez, David Broadbent, Ahmed A Zarea, Benedikt Dolgikh, Matthew P Bernard, Alicia Withrow, Amelia McGill, Victoria Toomajian, Lukose K Thampy, Jack Harkema and 5 more

Open access · goldAbstract read
In one paragraph

Article in Advanced genetics (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Gloria I PerezInstitute for Quantitative Health Science and Engineering (IQ) Michigan State University East Lansing Michigan 48824 USA.
David BroadbentInstitute for Quantitative Health Science and Engineering (IQ) Michigan State University East Lansing Michigan 48824 USA.
Ahmed A ZareaInstitute for Quantitative Health Science and Engineering (IQ) Michigan State University East Lansing Michigan 48824 USA.
Benedikt DolgikhInstitute for Quantitative Health Science and Engineering (IQ) Michigan State University East Lansing Michigan 48824 USA.
Matthew P BernardInstitute for Quantitative Health Science and Engineering (IQ) Michigan State University East Lansing Michigan 48824 USA.
Alicia WithrowCenter for Advanced Microscopy Michigan State University East Lansing MI 48824 USA.
Amelia McGillInstitute for Quantitative Health Science and Engineering (IQ) Michigan State University East Lansing Michigan 48824 USA.
Victoria ToomajianInstitute for Quantitative Health Science and Engineering (IQ) Michigan State University East Lansing Michigan 48824 USA.
Lukose K ThampyInstitute for Quantitative Health Science and Engineering (IQ) Michigan State University East Lansing Michigan 48824 USA.
Jack HarkemaDepartment of Pharmacology and Toxicology Michigan State University East Lansing MI 48824 USA.
Joel R WalkerPromega Biosciences LLC 227 Granada Dr San Luis Obispo CA 93401 USA.
Thomas A KirklandPromega Biosciences LLC 227 Granada Dr San Luis Obispo CA 93401 USA.
Michael H BachmannInstitute for Quantitative Health Science and Engineering (IQ) Michigan State University East Lansing Michigan 48824 USA.
Jens SchmidtInstitute for Quantitative Health Science and Engineering (IQ) Michigan State University East Lansing Michigan 48824 USA.
Masamitsu KanadaInstitute for Quantitative Health Science and Engineering (IQ) Michigan State University East Lansing Michigan 48824 USA.ORCID https://orcid.org/0000-0001-9025-9582
Michigan State University · USPromega (United States) · USPurdue University West Lafayette · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer cells produce heterogeneous extracellular vesicles (EVs) as mediators of intercellular communication. This study focuses on a novel method to image EV subtypes and their biodistribution in vivo. A red-shifted bioluminescence resonance energy transfer (BRET) EV reporter is developed, called PalmReNL, which allows for highly sensitive EV tracking in vitro and in vivo. PalmReNL enables the authors to study the common surface molecules across EV subtypes that determine EV organotropism and their functional differences in cancer progression. Regardless of injection routes, whether retro-orbital or intraperitoneal, PalmReNL positive EVs, isolated from murine mammary carcinoma cells, localized to the lungs. The early appearance of metastatic foci in the lungs of mammary tumor-bearing mice following multiple intraperitoneal injections of the medium and large EV (m/lEV)-enriched fraction derived from mammary carcinoma cells is demonstrated. In addition, the results presented here show that tumor cell-derived m/lEVs act on distant tissues through upregulating LC3 expression within the lung.

Indexed as

autophagybiodistributionbioluminescence resonance energy transferexosomesextracellular vesiclesmetastasismicrovesiclesm/lEVssEVs

Identifiers

PMID36619349
PMCPMC9744575
OpenAlexW4205808956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.